rs754559092
Variant summary
Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PM2BP4
The NM_012243.3(SLC35A3):c.405A>C(p.Lys135Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000434 in 1,613,042 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_012243.3 missense
Scores
Clinical Significance
Conservation
Publications
- autism spectrum disorder - epilepsy - arthrogryposis syndromeInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 1 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SLC35A3 | ENST00000533028.8 | c.405A>C | p.Lys135Asn | missense_variant | Exon 4 of 8 | 1 | NM_012243.3 | ENSP00000433849.1 | ||
| ENSG00000283761 | ENST00000639037.1 | c.405A>C | p.Lys135Asn | missense_variant | Exon 4 of 17 | 5 | ENSP00000492745.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152256Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00000798 AC: 2AN: 250694 AF XY: 0.00000738 show subpopulations
GnomAD4 exome AF: 0.00000411 AC: 6AN: 1460786Hom.: 0 Cov.: 30 AF XY: 0.00000275 AC XY: 2AN XY: 726688 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152256Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74380 show subpopulations ⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.405A>C (p.K135N) alteration is located in exon 4 (coding exon 3) of the SLC35A3 gene. This alteration results from a A to C substitution at nucleotide position 405, causing the lysine (K) at amino acid position 135 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Autism spectrum disorder - epilepsy - arthrogryposis syndrome Uncertain:1
This sequence change replaces lysine with asparagine at codon 135 of the SLC35A3 protein (p.Lys135Asn). The lysine residue is highly conserved and there is a moderate physicochemical difference between lysine and asparagine. This variant is present in population databases (rs754559092, ExAC 0.009%). This variant has not been reported in the literature in individuals affected with SLC35A3-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at